Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1730
https://www.valueinhealthjournal.com/article/S1098-3015(15)03806-1/fulltext
Title :
Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03806-1&doi=10.1016/j.jval.2015.09.1730
First page :
A544
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1157